Chargement en cours...
CXCR4 Antagonists as Stem Cell Mobilizers and Therapy Sensitizers for Acute Myeloid Leukemia and Glioblastoma?
Glioblastoma is the most aggressive and malignant primary brain tumor in adults and has a poor patient survival of only 20 months after diagnosis. This poor patient survival is at least partly caused by glioblastoma stem cells (GSCs), which are slowly-dividing and therefore therapy-resistant. GSCs a...
Enregistré dans:
| Publié dans: | Biology (Basel) |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7168055/ https://ncbi.nlm.nih.gov/pubmed/32079173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biology9020031 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|